Erlotinib/gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1850卷 / 1期

关键词：

D O I：

10.1007/s40278-021-93936-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：131 / 131

相关论文

共 50 条

[1] Gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2019, 1744 (1) : 138 - 138
[2] Erlotinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2020, 1811 (1) : 123 - 123
[3] Gefitinib/osimertinibDevelopment of resistance in small cell lung cancer: case report
Reactions Weekly, 2019, 1744 (1) : 139 - 139
[4] OsimertinibDevelopment of osimertinib resistance in non-small cell lung cancer with subsequent successful treatment with gefitinib: case report
Reactions Weekly, 2017, 1661 (1) : 255 - 255
[5] OsimertinibDevelopment of resistance in non-small cell lung cancer: 3 case reports
Reactions Weekly, 2021, 1880 (1) : 311 - 311
[6] Gefitinib/osimertinibAcquired resistance in advanced non-small cell lung cancer: case report
Reactions Weekly, 2021, 1863 (1) : 165 - 165
[7] Afatinib/erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1705 (1) : 15 - 15
[8] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
Shao, Yu-Yun
Lin, Chia-Chi
Yang, Chih-Hsin
DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
[9] Erlotinib/osimertinibDevelopment of resistance in lung adenocarcinoma: case report
Reactions Weekly, 2019, 1765 (1) : 158 - 158
[10] Erlotinib/osimertinibDevelopment of resistance in lung adenocarcinoma: case report
Reactions Weekly, 2019, 1749 (1) : 180 - 180

← 1 2 3 4 5 →